Ceftriaxone/Amikacin vs Ceftazidime/Amikacin as Empirical Therapy for Fever in Patients with Haemato...
Ceftriaxone/Amikacin vs Ceftazidime/Amikacin as Empirical Therapy for Fever in Patients with Haematological Malignancy and Severe Granulocytopenia: Clinical and Economic Outcomes
About this item
Full title
Author / Creator
Rossini, F , Pioltelli, P , Bolis, S , Borin, L , Casaroli, I , Lanzi, E , Maff??, P , Parma, M , Tripputi, P and Pogliani, EM
Publisher
New Zealand
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand
More information
Scope and Contents
Contents
To assess the economic outcomes produced when a conventional antibiotic treatment regimen requiring three administrations per day was replaced with a treatment regimen requiring only one daily administration, the efficacy, tolerability and cost of ceftazidime was compared with that of ceftriaxone (both drugs in combination with amikacin) for the em...
Alternative Titles
Full title
Ceftriaxone/Amikacin vs Ceftazidime/Amikacin as Empirical Therapy for Fever in Patients with Haematological Malignancy and Severe Granulocytopenia: Clinical and Economic Outcomes
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_734275270
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_734275270
Other Identifiers
ISSN
1173-2563
DOI
10.2165/00044011-199815050-00007
